InvestSMART

Anteris Technologies Ltd (ASX:AVR)

ALERT: Price-sensitive ASX Announcement for AVR
Current share price for AVR : $11.560 4.27 (58.57%)+
Announcement
Release
21 Jan 2026 3:17PM
Price at Release
$7.290
Full Release
download
Summary
Anteris Technologies Ltd, also known as Anteris, announced the pricing of its public offering, selling 34,782,609 shares at US$5.75 per share, raising approximately US$200 million before deducting costs. The offering is part of a strategy to support the company's growth, particularly in advancing clinical strategies like the DurAVR Transcatheter Heart Valve trial and expanding manufacturing capacities. A concurrent private placement agreement with Medtronic could raise up to an additional US$90 million. Proceeds from these offerings will also fund ongoing research, development, and corporate purposes.
Key Points
  • Public offering price set at US$5.75 per share.
  • Gross proceeds expected to be approximately US$200 million.
  • Offering expected to close by January 22, 2026, subject to conditions.
  • Company granted underwriters a 30-day option to purchase additional shares.
  • Private placement agreement with Medtronic for up to US$90 million.
  • Proceeds to support the DurAVR THV global trial and manufacturing expansion.
  • Joint book-running managers include Barclays and Wells Fargo Securities.
  • Offering registered with SEC and to be released to ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.